Need professional-grade analysis? Visit stockanalysis.com
$450.67B
50.30
20,602
N/A
Jiangsu Hengrui Pharma Co Ltd (1276) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at HKD66.40, down 3.14% from the previous close.
Over the past year, 1276 has traded between a low of HKD53.70 and a high of HKD94.10. The stock has gained 20.4% over this period. It is currently 29.4% below its 52-week high.
Jiangsu Hengrui Pharma Co Ltd has a market capitalization of $450.67B, with a price-to-earnings ratio of 50.30.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Side-by-side comparison against top Healthcare peers.